ArticleInsights into imaging2026
Noninvasive differentiation of benign and malignant solid pulmonary nodules using multiparameter dual-layer spectral CT radiomics.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo establish and validate a noninvasive multiparametric radiomics model based on dual-layer spectral CT (DLCT) for distinguishing preoperatively malignant from benign solid pulmonary nodules (SPNs). MATERIALS AND
methodsThis retrospective study enrolled 441 patients with pathologically confirmed SPNs who underwent preoperative DLCT and were divided into training (n = 252), internal test (n = 112), and external test (n = 77) cohorts. Radiomics features were extracted from conventional and virtual monoenergetic images (40 and 70 keV) and material decomposition images (including iodine density (ID), Z-effective atomic number (Zeff), and electron density (ED) maps) in arterial (AP) and venous (VP) phases. Logistic regression was used to construct radiomics models, and a combined clinical-radiomics model was visualized as a nomogram. Subgroup analysis was performed by nodule size (≤ 10 mm vs. > 10 mm), and diagnostic accuracy was compared with that of two radiologists.
resultsThe optimal radiomics model, comprising features from ID in VP and Zeff in both AP and VP, achieved an area under the curve (AUC) of 0.835, 0.804, and 0.772 in the training, internal, and external cohorts, respectively. The combined model (age, lobulation, and ten radiomic features) outperformed the clinical-radiological model in all cohorts (AUC: 0.889 vs. 0.816; 0.865 vs. 0.795; 0.825 vs. 0.743; p < 0.05). It maintained strong performance for ≤ 10 mm and > 10 mm nodules, with AUCs of 0.875 and 0.888 (internal test) and 1.000 and 0.794 (external test).
conclusionA DLCT-based multiparametric radiomics model, integrated with clinical-radiological features, enables accurate preoperative, noninvasive differentiation between benign and malignant SPNs, including subcentimeter nodules. KEY POINTS: Question: Accurate preoperative differentiation of solid pulmonary nodules remains clinically challenging because benign and malignant nodules often show overlapping features on conventional CT.
findingsA combined model integrating multiparameter dual-layer spectral CT radiomics and clinical-radiological features outperformed the clinical-radiological model in differentiating benign and malignant solid pulmonary nodules. Critical relevance statement: The developed model provides an accurate, noninvasive tool for preoperative differentiation of indeterminate solid pulmonary nodules, supporting clinical management decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.